Foundation Medicine is a world-leading molecular insights company, connecting physicians and their patients to the latest cancer treatment approaches and making precision medicine a reality for thousands.
In Malaysia, Roche’s pharmaceutical division is the licensed distributor of FoundationOne® CDx and FoundationOne® Liquid CDx (for patients with solid tumours) and FoundationOne® Heme (for patients with sarcomas), offering Comprehensive Genomic Profiling services and decision support tools that may inform cancer treatment decisions.
If you and your doctor decide that the FoundationOne® CDx, FoundationOne® Liquid CDx or FoundationOne® Heme test is right for you, your doctor will order the appropriate profile, and send a sample of your tumour or your blood to be analysed.
Allow up to seven days for your local laboratory in Malaysia to source and prepare your sample for shipment.
After the sample is received in USA, for FoundationOne® CDx or FoundationOne® Liquid CDx, it typically takes 14 days for your doctor to receive the report. FoundationOne® Heme takes approximately 21 days.